Hepatic inflammation and progressive liver fibrosis in chronic liver disease.
about
Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative ActivitiesOxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-AcetylcysteineRole of NADPH oxidases in the redox biology of liver fibrosisReview article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targetsReversibility and heritability of liver fibrosis: Implications for research and therapyGalectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitisDiagnosis and Management of Autoimmune Hepatitis: Current Status and Future DirectionsAn ω-3-enriched diet alone does not attenuate CCl4-induced hepatic fibrosisUltrasound Elastography: Review of Techniques and Clinical Applications.Expression of Septin4 in Schistosoma japonicum-infected mouse livers after praziquantel treatmentProtective effects of N-acetylcysteine in concanavalin A-induced hepatitis in mice.Inhibitory Effect of Delphinidin on Extracellular Matrix Production via the MAPK/NF-κB Pathway in Nasal Polyp-Derived Fibroblasts.Epigallocatechin 3-gallate ameliorates bile duct ligation induced liver injury in mice by modulation of mitochondrial oxidative stress and inflammation.Red blood cell distribution width levels correlate with liver fibrosis and inflammation: a noninvasive serum marker panel to predict the severity of fibrosis and inflammation in patients with hepatitis B.Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population.Experimental models of liver fibrosisAdiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver.Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) increases human hepatic stellate cell activation.Foetal programming by methyl donor deficiency produces steato-hepatitis in rats exposed to high fat diet.Hepatitis C Virus Infection of Cultured Human Hepatoma Cells Causes Apoptosis and Pyroptosis in Both Infected and Bystander Cells.Current and prospective pharmacotherapy for autoimmune hepatitis.Targeting apoptosis in autoimmune hepatitis.Update on implications and mechanisms of angiogenesis in liver fibrosis.HCV management in resource-constrained countries.Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis.Protective effect of human serum amyloid P on CCl4-induced acute liver injury in miceClinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis C.Ligustrazine-Oleanolic Acid Glycine Derivative, G-TOA, Selectively Inhibited the Proliferation and Induced Apoptosis of Activated HSC-T6 Cells.Evolving paradigm of treatment for autoimmune hepatitis.Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV InfectionCell therapy in chronic liver disease.Nature and Implications of Oxidative and Nitrosative Stresses in Autoimmune Hepatitis.Targeting Hepatic Fibrosis in Autoimmune Hepatitis.Adverse outcome pathway development from protein alkylation to liver fibrosis.Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases.Editor's Highlight: Modeling Compound-Induced Fibrogenesis In Vitro Using Three-Dimensional Bioprinted Human Liver Tissues.Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury.Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study.Influence of cytokine and cytokine receptor gene polymorphisms on the degree of liver damage in patients with chronic hepatitis C.
P2860
Q26752622-23929469-2A8C-4C9C-9F51-C4B8C15414AEQ26773384-E6EBB682-ADEA-42CC-A979-6CBAD1422B03Q26800143-8263AAB9-F4A7-42EC-8D7C-F91A85D670DBQ27025680-5491B914-8698-4E7E-A2BA-D272A4587244Q27026622-415543EF-5BD3-4ADD-A601-59341CFA7017Q28069174-28E85636-0446-4F8E-B977-182C44F95FCAQ28076505-7ED2CC99-285C-495B-9895-1A9D94283880Q28393724-A1E5352B-4A7B-4CC7-8C4C-E90353E3791EQ30358290-EF281CCE-3D38-4A3F-B317-D82318BB50DAQ34984531-8B15CA03-20E1-494B-A53D-19BE83CB09D9Q35189229-FDB58E3D-6F1D-4AC6-83D3-775DD114682AQ35420612-C7A70E51-45B4-4719-9099-401E118D6915Q35586755-887EB3D3-F863-4F81-BF56-8EE557246000Q36151026-15D3563C-18A9-4F40-A1DB-8863E1BF7E4DQ36306317-F57B56A0-39EE-46CF-A292-A5365160C08EQ36442525-4C4067EF-6E71-48EC-BA5A-8E90FA480C30Q36551969-A32D62FA-03DF-46B3-8179-6C15D9DC7F85Q36689584-D381051E-5D4F-4F5D-B461-076543D6A246Q37419162-719B810C-7B50-4A15-9192-7D830FDB39F3Q37504457-785CC430-0AC5-4AA5-9B4E-A2A77900EC6FQ38222882-DEAA0C34-4459-42C8-BE0C-CCA6C6B5F67CQ38231217-C3CEE181-9BEA-4CDE-B1D3-9E5BA0A9D5C3Q38246718-7F5532D7-B9B1-4430-8158-DB6EA1C493CFQ38372939-8071AFAE-7B9C-462B-98F5-13B16ABDF1A3Q38496935-69B57FF3-C66A-44B3-96A6-834DF244F797Q38684604-588DEF27-4175-4C6F-8ABD-766BAC889D58Q38719582-18E66463-5FC3-4C4D-BB0B-A9D06E2801D1Q38726664-0610A482-4176-4C01-972B-BBE03B381E4EQ38729032-35486196-D5C8-4A36-B319-50786BF38113Q38730872-59DFF81B-B0C1-4144-B1C8-5F3F71212018Q38749963-A0484C27-F820-495E-B6C2-4664210C028CQ38763661-1E95FD2B-5FFD-493A-B924-7E53B1A0F885Q38895458-79AC9D21-9279-48E4-84C7-2EA8947503BCQ38902371-ED83980D-2799-47F1-BCBF-FFE30A5FF087Q38932043-AF21C2DB-308F-44F6-94C8-7F999A3581ADQ39077570-2095B74F-6D54-4DAC-9539-5178C18898BAQ39412233-A41C5785-E52A-491B-8C78-CC22139E9B21Q40229016-6A47AF60-85CE-4D5C-A844-651E680B1CD6Q40460115-2EBE7631-342A-4123-95FF-412B19FBA4CFQ40666389-505D9C85-6E5B-4398-AE13-8256E12DF1F8
P2860
Hepatic inflammation and progressive liver fibrosis in chronic liver disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatic inflammation and progressive liver fibrosis in chronic liver disease.
@en
Hepatic inflammation and progressive liver fibrosis in chronic liver disease.
@nl
type
label
Hepatic inflammation and progressive liver fibrosis in chronic liver disease.
@en
Hepatic inflammation and progressive liver fibrosis in chronic liver disease.
@nl
prefLabel
Hepatic inflammation and progressive liver fibrosis in chronic liver disease.
@en
Hepatic inflammation and progressive liver fibrosis in chronic liver disease.
@nl
P2860
P356
P1476
Hepatic inflammation and progressive liver fibrosis in chronic liver disease.
@en
P2093
Albert J Czaja
P2860
P304
P356
10.3748/WJG.V20.I10.2515
P407
P577
2014-03-01T00:00:00Z